Bioequivalence of a biosimilar enoxaparin (Cloti‐Xa™) and its innovator (Clexane(®)): A single‐dose, randomized, double‐blind, two‐period, two‐treatment, two‐sequence, crossover, b...

por Saxena, Sumit, Chaudhary, Manu, Chaudhary, Saransh, Aggarwal, Anmol
Publicado 2022

Polymyxin B-Induced Kidney Injury Assessment of a Novel Formulation of Polymyxin B (VRP-034) in Rats

por Roy, Dilip, Kulkarni, Amol, Chaudhary, Manu, Chaudhary, Saransh, Payasi, Anurag, Aggarwal, Anmol
Publicado 2021

P07 Toxicokinetic profile of VRP-034

por Murkunde, Yogeshkumar Vishnupant, Chaudhary, Saransh, Vishwakarma, Kamlesh Kumar, Aggarwal, Anmol, Chilbule, Rahul
Publicado 2022

P06 Pharmacokinetics and renal accumulation of VRP-034

por Vishwakarma, Kamlesh Kumar, Chilbule, Rahul, Chaudhary, Manu, Sharma, Arun, Chaudhary, Saransh, Aggarwal, Anmol
Publicado 2022

P05 In vivo efficacy of VRP-034 in lung and thigh infection models

por Vishwakarma, Kamlesh Kumar, Payasi, Anurag, Kumar, Shailesh, Sharma, Arun, Chaudhary, Saransh, Aggarwal, Anmol
Publicado 2022